There is a debate about the use of GHK-Cu in combination with other peptides, such as TB500 and BPC157, with some people referring to the combination as the "glow stack", although there is a concern about the potential denaturing of peptides when mixed together 8m40s
Previous attempts at treatment and the severity of tissue damage also matter
Neuroprotection Emerging Evidence Evidence Rating: Emerging (Interesting animal data, limited scope) Neurological applications show promise but require more research: Dopaminergic system protection Peripheral nerve regeneration Traumatic brain injury Alcohol-related neurological damage The GABAergic system interactions and NO modulation provide mechanistic support, but this area needs more study
A deficiency in B-12 can lead to neurological and circadian rhythm disturbances, which affects melatonin production
Baseline bloodwork before starting BPC-157 establishes reference values for comparison
These therapies are especially helpful when used alongside testosterone replacement therapy and GLP-1 medications like semaglutide (Ozempic) or tirzepatide (Zepbound)
